#VisualAbstract: Ibrutinib-Venetoclax Improves Progression-Free Survival in Chronic Lymphocytic Leukemia

Click here to read this study in NEJM.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

#VisualAbstract: Ibrutinib-Venetoclax Improves Progression-Free Survival in Chronic Lymphocytic Leukemia

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

Current expert consensus for the treatment of adult patients with drug reaction with eosinophilia and systemic symptoms

Concurrent strength and endurance training in females increases parameters associated with maximal strength and endurance capacity

RelatedReports

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

Concurrent strength and endurance training in females increases parameters associated with maximal strength and endurance capacity

Low income associated with worse cardiovascular health in middle-aged adults

#VisualAbstract: Low-dose amitriptyline effective and well-tolerated for management of irritable bowel syndrome

2MM+ All Access

Look up any US clinician

Recent Reports

Get the app

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits